Edition:
United States

Vivus Inc (VVUS.OQ)

VVUS.OQ on NASDAQ Stock Exchange Global Select Market

0.91USD
25 May 2018
Change (% chg)

$-0.02 (-2.20%)
Prev Close
$0.93
Open
$0.96
Day's High
$0.99
Day's Low
$0.88
Volume
534,601
Avg. Vol
190,168
52-wk High
$1.38
52-wk Low
$0.33

Chart for

About

VIVUS, Inc. is a biopharmaceutical company. The Company operates in the development and commercialization of therapeutic products segment. It provides over two therapies approved by the Food and Drug Association (FDA), which include Qsymia (phentermine and topiramate extended-release) for chronic weight management and STENDRA... (more)

Overall

Beta: 1.10
Market Cap(Mil.): $96.92
Shares Outstanding(Mil.): 106.04
Dividend: --
Yield (%): --

Financials

  VVUS.OQ Industry Sector
P/E (TTM): -- 29.19 33.30
EPS (TTM): -0.38 -- --
ROI: -16.57 13.53 13.04
ROE: -- 15.25 14.90

BRIEF-Vivus Says Got Letter From Nasdaq Informing that it Granted Co's Request For Continued Listing, On Conditions

* VIVUS SAYS ON MAY 17, GOT LETTER FROM NASDAQ INFORMING NASDAQ HEARINGS PANEL GRANTED CO'S REQUEST FOR CONTINUED LISTING, ON CONDITIONS- SEC FILING Source text: (https://bit.ly/2KyiHGO) Further company coverage: (Reuters.Briefs@thomsonreuters.com)

May 18 2018

BRIEF-Vivus Announces Change In Leadership

* VIVUS INC - BOARD MEMBER THOMAS B. KING APPOINTED INTERIM CEO

Dec 26 2017

Competitors

Earnings vs. Estimates